Intervention Review

Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease

  1. Richard W Orrell1,*,
  2. Russell JM Lane2,
  3. Mark Ross3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 21 JUN 2010

DOI: 10.1002/14651858.CD002829.pub4


How to Cite

Orrell RW, Lane RJM, Ross M. Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002829. DOI: 10.1002/14651858.CD002829.pub4.

Author Information

  1. 1

    University College London Institute of Neurology, Department of Clinical Neurosciences, London, UK

  2. 2

    Imperial College NHS Trust, West London Neurosciences Centre, London, UK

  3. 3

    Mayo Clinic Scottsdale, Department of Neurology, Scottsdale, Arizona, USA

*Richard W Orrell, Department of Clinical Neurosciences, University College London Institute of Neurology, Royal Free Campus, Rowland Hill Street, London, NW2 3PF, UK. r.orrell@ucl.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 24 JAN 2007

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amit Prabhakar, Christopher Paul Owen, Alan David Kaye, Anesthetic management of the patient with amyotrophic lateral sclerosis, Journal of Anesthesia, 2013, 27, 6, 909

    CrossRef

  2. 2
    Barkha P. Patel, Mazen J. Hamadeh, Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis, Clinical Nutrition, 2009, 28, 6, 604

    CrossRef

  3. 3
    Zhan-Miao Yi, Fang Liu, Suo-Di Zhai, Jerry Belsh, Si-Yan Zhan, Philip Schiffman, Pharmacological interventions for improving respiratory function in amyotrophic lateral sclerosis, The Cochrane Library,